Breast cancer: Analysis of treatment quality in Germany 2004: Retrospective survey by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO);Das mammakarzinom: Versorgungslage und therapiequalität in Deutschland 2004: Eine retrospektive analyse der organgruppe mamma der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)

Zentralblatt fur Gynakologie

Volumn 128, Issue 6, 2006, Pages 352-361

  Jackisch, Christian ^a   Untch, M ^b   Chatsiproios, D ^c   Lamparter, C ^d   Overkamp, F ^e   Lichtenegger, W ^f   Ronsberg W ^g   Thomssen, C ^h   Von Minckwitz, C ^i,j  

^a Klinikum Offenbach GmbH   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c CGG Klinik GmbH   (Germany)

^d MMF GmbH   (Germany)

^e Praxis und Tagesklinik für Onkologie   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Dr Rönsberg GmbH   (Germany)

^h MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁱ GERMAN BREAST GROUP   (Germany)

^j UNIVERSITY HOSPITAL FRANKFURT   (Germany)

more..

Author keywords

Adjuvant treatment; Analysis of care; Breast cancer; Guidelines; Metastatic breast cancer

Indexed keywords

ANTHRACYCLINE; CAPECITABINE; CYCLOPHOSPHAMIDE; GEMCITABINE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ARTICLE; BREAST CANCER; CLINICAL PRACTICE; HEALTH SURVEY; HUMAN; METASTASIS; POSTOPERATIVE PERIOD;

EID: 33846264834     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-955230     Document Type: Article

References (16)

1. Bonadonna G, Valagussa P, Moliterni A et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. Results of 20 years of follow-up. N Engl J Med 1995; 332: 901-906
2. Davidson NE. Breast cancer consensus meetings: Vive la différence? J Clin Oncol 2002; 20: 1719-1720
3. duBois A, Rochon J, Lamparter C et al. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. In J Gynecol Cancer 2005; 15: 183-191
4. Goldhirsch A, Wood WC, Gelber RD et al. Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer. J Clin Oncol 2003; 21: 3357-3365
5. Hebert-Croteau N, Brisson J, Latreille J et al. Compliance with consensus recommendations for systemic therapy associated with improved survival of women with node-negative breast cancer. J Clin Oncol 2004; 22: 3685-3693
6. Huober J, Jackisch C, Untch M et al. Adjuvant therapy with trastuzumab (Herceptin) in primary breast cancer. Zentralbl Gynaekol 2006; 128: 30-37
7. Jackisch C, Gerber B, Jonat W. Aromatasehemmer in der adjuvanten Hormontherapie des Mammakarzinoms. Frauenarzt 2006; 45: 5002-5004
8. Kaufmann M, Hortobagyi GN, Goldhirsch A et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006; 24: 1940-1949
9. Levi F, Lucchini F, Negri E et al. The fall in breast cancer mortality in Europe. Eur J Cancer 2001; 37: 1409-1412
10. Muss H, Woolf S, Berry D et al. Adjuvant Chemotherapy in Older and Younger Women With Lymph Node-Positive Breast Cancer. JAMA 2005; 293: 1073-1081
11. Nowak AK, Wilcken NRC, Stockler MR et al. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncol 2004; 5: 372-380
12. Schulz KD, Koller M, Lorenz W et al. Short version of the guideline "Early Detection of Breast Cancer in Germany". Z Arztl Fortbild Qualitatssich 2004; 98: 361-373
13. Schwengklenks M, Jackisch C, Constenla M et al. Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment. Support Cancer Care 2006; 14: 901-909
14. Robert Koch Institut. http://www.rki.de/cln_006/nn_403600/DE/Content/GBE/ Gesundheitsberichterstattung/GBEDownloadsT/brustkrebs, templateId=raw,property= publicationFile.pdf/brustkrebs. Berlin 2005
15. Minckwitz G von, Brunnert K, Costa SD et al. Evidence based recommendations on primary treatment of carcinomas of the breast. Zentralbl Gynakol 2002; 124: 293-303
16. Wood WC, Anderson M, Lyles RH et al. Can we select which patients with small breast cancers should receive adjuvant chemotherapy. Ann Surg 2002; 235: 859-862